Microfluidic-Based POC Device for Detection and Analysis of HIV Directly From Blood
Microfluidic-Based POC Device for Detection and Analysis of HIV Directly From Blood Client/Summary Chipcare, a biotech company specializing in multiplexed Point-of-Care (POC) diagnostics for sexually transmitted infections, approached Gener8 to develop a turnkey sample-to-answer POC device and microfluidic-based cartridge for analyzing blood from HIV patients. The goal was to create a diagnostic device that would…
Gener8 Celebrates 20 Years of Business and Continued Growth
Gener8 Celebrates 20 Years of Business and Continued Growth Sunnyvale, California – September 16th, 2022 Gener8 LLC (“Gener8”), a portfolio company of Sverica Capital Management LP (“Sverica”), celebrates the company’s 20th anniversary this month. Since its founding in September 2002 Gener8 has developed into a full product lifecycle engineering and manufacturing partner, successfully serving the…
Gener8 Welcomes Mark Chatfield as Global Vice President of Operations
Sunnyvale, California – February 9, 2022 Gener8 LLC (“Gener8”), a portfolio company of Sverica Capital Management LP (“Sverica”), welcomes Mark Chatfield as the new Global Vice President of Operations. Mark brings thirty years of experience with Thermo Fisher Scientific running operations in the fields of specialized x-rays, chromatography, and mass spectroscopy. “We are lucky to…
Gener8 Has Acquired RND, Expanding Into Life Sciences Software Development
Sunnyvale, California – December 9, 2021 Gener8 LLC (“Gener8”), a portfolio company of Sverica Capital Management LP (“Sverica”), announced today that it has completed its acquisition of the RND Group (“RND”), a leading provider of software development focused on medical device and life science products, based in Indianapolis, Indiana. With the acquisition of RND, Gener8…
Gener8 Reorganizes Carlsbad Facility for Expanded Manufacturing Capabilities
SUNNYVALE, Calif., June 30, 2021, Gener8 LLC (“Gener8”), a provider of full product lifecycle engineering and manufacturing solutions for highly complex instruments and products within the life sciences and medical device markets, together with its capital partner, Sverica Capital Management LP, is restructuring its 15,000 sq. ft. Carlsbad facility to provide microfluidics cartridge design, development, and manufacturing under one…
Gener8 Expands into New Boston Location
SUNNYVALE, Calif., June 17, 2021 — Gener8 LLC (“Gener8”), a provider of full product lifecycle engineering and manufacturing solutions for highly complex instruments and products within the life sciences and medical device markets, together with its capital partner, Sverica Capital Management LP, announced today that it has expanded its services to a new location in…
Gener8 Names Jerry Jurkiewicz as New Chief Executive Officer
Sunnyvale, California, March 25, 2021 – Gener8 LLC, a provider of full product lifecycle engineering and manufacturing solutions for highly complex instruments and products within the life sciences and medical device markets, together with its capital partner, Sverica Capital Management LP, announced today the placement of Jerry Jurkiewicz as Chief Executive Officer. This appointment helps…
Welcome to Gener8, An Exceptional Product Development and Engineering Consulting Firm
Since its inception, Gener8 has been delivering exceptional product development and engineering consulting services. By working with us, clients innovate at a speed and scale that continuously outpaces their competition. Throughout the years, we have designed a variety of cutting edge products for multiple industries. While we are comfortable leaning into the intricacies of any…